ClinicalTrials.Veeva

Menu

Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics (Eyesinglecell)

N

Nanjing Medical University

Status

Unknown

Conditions

Proliferative Vitreoretinopathy
Glaucoma
Pterygium
Diabetic Retinopathy

Treatments

Procedure: ocular surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT04682054
Eyesinglecell

Details and patient eligibility

About

The surgically-harvested eye tissue (ie. vitreous-retinal proliferative membrane, outflow pathway, retinas, and pterygium) is a complex tissue responsible for maintaining intraocular homeostasis or mediating ocular pathogenesis. Dysfunction of one or more resident cell types within the tissues results in different ocular disorder, leading to vision loss, or even blindness. In this study, we aim to use single-cell RNA sequencing to generate a comprehensive cell atlas of surgically-harvested eye tissues.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with ocular diseases and require surgery intervention.
  2. The surgery intervention remove pathological tissue during surgery.
  3. Patients consent to the treatment and single-cell sequencing.

Exclusion criteria

  1. Surgically removed eye tissue cannot meet with the quality control of single-cell sequencing (mainly the tissue weight and cell counts);

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

80 participants in 1 patient group

surgically-removed eye tissue
Experimental group
Treatment:
Procedure: ocular surgery

Trial contacts and locations

1

Loading...

Central trial contact

Zizong Hu, PhD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems